ArticleOncotarget2016

Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine.

Huilin Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.